Oligonucleotide Synthesis Market Overview, Trends, Growth, Demand, Key Players Analysis and Forecast to 2031 | Agilent Technologies, Inc., Bio-Synthesis, Inc., Eurofins Scientific SE, GenScript USA, In, Alnylam Pharmaceutical Inc

New York, 2022-Jul-14 — /EPR Network/ — Global Oligonucleotide Synthesis Market report from Global Insight Services is the single authoritative source of intelligence on Oligonucleotide Synthesis Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Oligonucleotide synthesis is the process of making oligonucleotides, which are short strands of nucleotides. Nucleotides are the building blocks of DNA and RNA, and they are made up of a phosphate group, a sugar group, and a nitrogenous base. The phosphate group and the sugar group make up the backbone of the nucleotide, and the nitrogenous base is attached to the sugar group.

Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS20211/

Key Trends

The main trend in oligonucleotide synthesis technology is the move towards automated synthesis. This is driven by the need for high throughput and the need for consistent quality control. Automated synthesis also enables the use of novel chemistries and modifications, which can improve the performance of oligonucleotides.

Key Drivers

The main drivers of the oligonucleotide synthesis market are the increasing demand for nucleic acid-based therapeutics and the rising demand for personalized medicine. The increasing demand for nucleic acid-based therapeutics is due to the growing demand for treatments for cancer and genetic diseases. The rising demand for personalized medicine is due to the increasing incidence of genetic diseases and the need for more personalized and targeted treatments.

 

Market Segments

By Product

  • Oligonucleotide-based drugs
  • Synthesized oligonucleotides
  • Reagents

By Application

  • Therapeutic applications
  • Research applications
  • Diagnostic applications

By End User

  • Hospitals
  • Pharmaceutical & biotechnology companies
  • Diagnostic laboratories
  • CROs and CMOs

By Region

  • North America

Request For Customization – https://www.globalinsightservices.com/request-customization/GIS20211/

Key Players

  • Agilent Technologies, Inc.
  • Bio-Synthesis, Inc.
  • Eurofins Scientific SE
  • GenScript USA, In
  • Alnylam Pharmaceutical Inc
  • Biogen limited
  • Cinven
  • Danaher Corporation
  • Eurofins Scientific
  • Ionis Pharmaceuticals Inc

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Excel data pack included with all report purchases
  • Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1–833–761–1700

Matched content

Editor’s pick

Express Press Release Distribution